Abbott Continues to be Investigated Over Depakote
Attorneys Generals in eight states have come together to form a committee that will probe Abbott Laboratories in connection to the drugmaker’s sales and marketing of its seizure medication Depakote.
According to Dow Jones Newswires, the Attorney Generals are from Illinois, Ohio, Florida, North Carolina, South Carolina, Pennsylvania and Texas. They will attempt to determine if Abbott violated various state consumer-protection and other laws in their marketing and sales of Depakote.
Abbott has had to undergo a separate investigation last year by the Justice Department and had to set aside $1.5 million to settle allegations that it marketed Depakote for unapproved uses, such as treating the elderly for aggression and agitation. The dangerous drug has only been approved to treat migraine headaches, manic episodes associated with bipolar disorder and epilepsy.
Some of Abbott’s current and former top executives and directors are also facing eight lawsuits that allege breaches of fiduciary duty linked to certain business practices surrounding the promotions and sales of Depakote.